BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Born HA, Martinez LA, Levine AT, Harris SE, Mehra S, Lee WL, Dindot SV, Nash KR, Silverman JL, Segal DJ, Weeber EJ, Anderson AE. Early Developmental EEG and Seizure Phenotypes in a Full Gene Deletion of Ubiquitin Protein Ligase E3A Rat Model of Angelman Syndrome. eNeuro 2021;8:ENEURO. [PMID: 33531368 DOI: 10.1523/ENEURO.0345-20.2020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Beitnere U, Vilanova-Cuevas B, Christian SG, Taylor C, Berg EL, Copping NA, Dindot SV, Silverman JL, Gareau MG, Segal DJ. Unique Features of the Gut Microbiome Characterized in Animal Models of Angelman Syndrome. mSystems 2023;:e0060822. [PMID: 36598241 DOI: 10.1128/msystems.00608-22] [Reference Citation Analysis]
2 Beitnere U, Vilanova-cuevas B, Christian SG, Taylor C, Berg EL, Copping NA, Dindot SV, Silverman JL, Gareau MG, Segal DJ. Unique features of the gut microbiome characterized in animal models of Angelman Syndrome.. [DOI: 10.1101/2022.07.05.498914] [Reference Citation Analysis]
3 Lee D, Chen W, Kaku HN, Zhuo X, Chao ES, Soriano A, Kuncheria A, Flores S, Kim JH, Rigo F, Jafar-nejad P, Beaudet AL, Caudill MS, Xue M. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.. [DOI: 10.1101/2022.06.18.496687] [Reference Citation Analysis]
4 Nenninger AW, Willman M, Willman J, Stewart E, Mesidor P, Novoa M, Morrill NK, Alvarez L, Joly-Amado A, Peters MM, Gulick D, Nash KR. Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A. Neurotherapeutics 2022. [PMID: 35534672 DOI: 10.1007/s13311-022-01239-2] [Reference Citation Analysis]
5 Levin Y, Hosamane NS, McNair TE, Kunnam SS, Philpot BD, Fan Z, Sidorov MS. Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep. Autism Res 2022. [PMID: 35304979 DOI: 10.1002/aur.2709] [Reference Citation Analysis]
6 Dodge A, Morrill N, Weeber EJ, Nash KR. Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation. Molecular and Cellular Neuroscience 2022. [DOI: 10.1016/j.mcn.2022.103724] [Reference Citation Analysis]
7 Berg EL, Silverman JL. Animal models of autism. The Neuroscience of Autism 2022. [DOI: 10.1016/b978-0-12-816393-1.00010-5] [Reference Citation Analysis]
8 Berg EL, Petkova SP, Born HA, Adhikari A, Anderson AE, Silverman JL. Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome. Mol Autism 2021;12:59. [PMID: 34526125 DOI: 10.1186/s13229-021-00467-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Berg EL, Petkova SP, Born HA, Adhikari A, Anderson AE, Silverman JL. Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome.. [DOI: 10.1101/2021.08.13.456299] [Reference Citation Analysis]
10 Yang L, Shu X, Mao S, Wang Y, Du X, Zou C. Genotype-Phenotype Correlations in Angelman Syndrome. Genes (Basel) 2021;12:987. [PMID: 34203304 DOI: 10.3390/genes12070987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]